The core role of CRBN ligands in PROTAC drug development and their binding evaluation techniques

Author: Senior Product Manager of UA Views：55

This article focuses on the central role of CRBN (Cereblon) ligands in the field of targeted protein degradation, systematically elaborating their advantages as E3 ligase ligands in the design of PROTACs and molecular glues, and analyzing the chemical space advantages of CRBN-based PROTACs in oral absorption.

Recent Advances
Product Information

Recent Advances

The Central Role of CRBN Ligands in PROTAC Drug Development and Binding Evaluation Technologies

Overview
This article focuses on the central role of CRBN (Cereblon) ligands in the field of targeted protein degradation, systematically elaborating their advantages as E3 ligase ligands in PROTAC and molecular glue design, and analyzing the chemical space advantages of CRBN-based PROTACs in oral absorption.

I. The Rise of CRBN Ligands in Targeted Protein Degradation

In recent years, CRBN ligands have gradually become one of the most popular E3 ligase ligands in the design of PROTACs (Proteolysis Targeting Chimeras) and molecular glue degraders. CRBN is the substrate recognition component of the CUL4-RBX1-DDB1 E3 ubiquitin ligase complex, which recruits various substrate proteins for ubiquitination modification, thereby achieving targeted degradation through the proteasome pathway. Currently, the CRBN ligands used in PROTACs and molecular glues are still these immunomodulatory inhibitors and their derivatives.

II. Advantages of CRBN PROTACs Compared to VHL PROTACs

In PROTAC design, the two most commonly used E3 ligases are VHL and CRBN. However, CRBN-based PROTACs exhibit superior chemical space properties in terms of oral absorption. CRBN ligands themselves have smaller molecular weights and more favorable physicochemical properties, making CRBN PROTACs more likely to comply with the Rule of Five for oral drugs. This advantage has been validated in several CRBN PROTACs entering clinical studies, providing an important foundation for the development of oral administration routes in targeted protein degradation technology.

III. Mechanism of PROTAC Action and the Recruitment Function of CRBN Complexes

PROTAC is a heterobifunctional small molecule that binds to the target protein (e.g., CDK4) at one end and the substrate recognition subunit of the E3 ligase (e.g., CRBN) at the other, thereby inducing the formation of a ternary complex between the target protein and the E3 ligase. The target protein is polyubiquitinated by the E3 ligase complex and ultimately recognized and degraded by the proteasome. In the CDK4/CRBN system, CRBN and CDK4 form a ternary complex mediated by the PROTAC molecule. The binding of CDK4 to CRBN depends on the G-loop domain of CDK4, which can embed into the hydrophobic pocket of CRBN, mediated by key residues such as Asn351, His357, and Trp400 in CRBN.

IV. Application of TR-FRET Technology in CDK4/CRBN PROTAC Binding Assays

Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology combines the dual advantages of fluorescence resonance energy transfer and time-resolved fluorescence detection, making it a highly efficient and sensitive homogeneous detection method. The core of this technology lies in the use of lanthanide chelates (e.g., europium Eu³⁺ or terbium Tb³⁺) as energy donors, whose fluorescence half-life is as long as milliseconds, far exceeding the nanosecond-level half-life of ordinary fluorescent substances. By setting an appropriate delay detection time (typically 50-150 microseconds), short-lived background fluorescence and non-specific scattered light can be effectively attenuated, significantly improving the signal-to-noise ratio and detection sensitivity.

In the CDK4/CRBN PROTAC binding assay system, recombinant CDK4 protein with specific tags (e.g., GST-His double tags) binds to a fluorescence donor-labeled anti-tag antibody, while FLAG-tagged CRBN protein binds to a fluorescence acceptor-labeled anti-FLAG antibody. When the test PROTAC molecule simultaneously binds to CDK4 and CRBN, the two proteins are brought within the effective FRET distance (<10nm), and the energy from the donor excitation can transfer to the acceptor, producing a specific fluorescence signal. The signal intensity is positively correlated with the amount of ternary complex formation, reflecting the bridging activity of the PROTAC molecule.

V. Conclusion

CRBN ligands have evolved from initial immunomodulators to one of the most core E3 ligase ligands in PROTAC and molecular glue design. The advantages of CRBN-based PROTACs in oral absorption have driven the development of multiple clinical candidate compounds. TR-FRET technology, with its homogeneous operation, high signal-to-noise ratio, and high-throughput compatibility, provides an efficient and reliable detection platform for CDK4/CRBN PROTAC binding evaluation, playing a significant tool value in the discovery and optimization of targeted protein degradation drugs.

UniOne offers the UniOne® TR-FRET Human CDK4/CRBN PROTAC Binding Kit, which employs a homogeneous "add-incubate-read" three-step workflow, eliminating the need for washing and separation steps, and is compatible with high-throughput operations in 96-well or 384-well plates. The kit includes purified recombinant CDK4/Cyclin D3 complex (GST-His tagged), purified recombinant CRBN protein (FLAG tagged), positive control PROTAC molecules, and negative control compounds. All components undergo strict quality control to ensure inter-batch consistency and experimental reproducibility. This kit is primarily used for PROTAC molecule activity evaluation and structural optimization studies. By constructing dose-response curves based on TR-FRET signal changes induced by different PROTAC concentrations, the half-maximal effective concentration (EC₅₀) can be calculated, enabling direct comparison of bridging efficiency among different PROTAC candidate molecules.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next